Dr Michael Watson, MD

Michael Watson has a high-level expertise in the structure and drivers of global health and national policy. He started his career as an internal physician at the NHS, before joining the biopharmaceutical industry and holds a track record of executive leadership positions for several vaccine technology manufacturers. Overall, Mike brings over 20 years of leadership of industry groups and foundation board membership enabling an extensive network of global funders, policymakers, and influencers.

Prior experience:
• CEO/Executive Chair, VaxEquity Ltd (2020-current)
• CEO, MEVOX Ldt (2021 – current)
• Board Member and Chair of the Remuneration Committee, FIND (2014 – current)
• Vaccine Consultant on SARS-COV-2, Moderna (2020)
• President of Infectious Diseases Strategy and Vaccines Venture, Valera/Moderna (2016 – 2019)
• Global Head of Policy & Advocacy, Sanofi (2009 – 2016)
• Head of R&D and Board Member, Acambis (2007 – 2009)
• Executive Director Clinical and Epidemiology Europe, Sanofi Pasteur MSD (2001 – 2007)
• Medical Director UK and Ireland, Sanofi Pasteur MSD (1998 – 2001)

• Clinical Project Scientist, Takeda (1995 – 1998)
• Senior Medical Advisor Cardiovascular, Bristol-Myers Squibb (1993 – 1995)
• Internal Hospital Physician, NHS (1988 – 1993)
• Executive Director Clinical and Epidemiology Europe, Sanofi Pasteur MSD (2001 – 2007)
• Medical Director UK and Ireland, Sanofi Pasteur MSD (1998 – 2001)

 

Education:
• Medical Degree from the University of Birmingham
• Member of the Royal College of Physicians